359 related articles for article (PubMed ID: 28666611)
1. Treatment of xanthelasma palpebrarum with a 1064-nm, Q-switched Nd:YAG laser.
Heng JK; Chua SH; Goh CL; Cheng S; Tan V; Tan WP
J Am Acad Dermatol; 2017 Oct; 77(4):728-734. PubMed ID: 28666611
[TBL] [Abstract][Full Text] [Related]
2. Is Q-switched neodymium-doped yttrium aluminium garnet laser an effective approach to treat xanthelasma palpebrarum? Results from a clinical study of 76 cases.
Karsai S; Schmitt L; Raulin C
Dermatol Surg; 2009 Dec; 35(12):1962-9. PubMed ID: 19708874
[TBL] [Abstract][Full Text] [Related]
3. Treatment of xanthelasma palpebrarum by 1064-nm Q-switched Nd:YAG laser: a study of 11 cases.
Fusade T
Br J Dermatol; 2008 Jan; 158(1):84-7. PubMed ID: 17916214
[TBL] [Abstract][Full Text] [Related]
4. About the treatment of xanthelasma palpebrarum using a 1,064 Q-switched neodymium-doped yttrium aluminum garnet laser.
Fusade T
Dermatol Surg; 2011 Mar; 37(3):403-4. PubMed ID: 21410824
[No Abstract] [Full Text] [Related]
5. Erbium:yttrium aluminum garnet laser versus Q-switched neodymium:yttrium aluminum garnet laser for the treatment of xanthelasma palpebrarum.
Balevi A; Ustuner P; Ozdemir M
J Cosmet Laser Ther; 2017 Apr; 19(2):100-105. PubMed ID: 27849400
[TBL] [Abstract][Full Text] [Related]
6. 1064-nm Q-switched Nd:YAG laser is an effective and safe approach to treat xanthelasma palpebrarum in Asian population.
Zhao Y; Wen CM; Zhou NN; Feng Q; Tu P
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2263-5. PubMed ID: 24909746
[No Abstract] [Full Text] [Related]
7. Combination of CO2 and Q-switched Nd:YAG lasers is more effective than Q-switched Nd:YAG laser alone for eyebrow tattoo removal.
Radmanesh M; Rafiei Z
J Cosmet Laser Ther; 2015 Apr; 17(2):65-8. PubMed ID: 25411720
[TBL] [Abstract][Full Text] [Related]
8. A low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminium garnet laser for the treatment of café-au-lait macules.
Kim HR; Ha JM; Park MS; Lee Y; Seo YJ; Kim CD; Lee JH; Im M
J Am Acad Dermatol; 2015 Sep; 73(3):477-83. PubMed ID: 26169691
[TBL] [Abstract][Full Text] [Related]
9. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
10. Systematic review of laser therapy in xanthelasma palpebrarum.
Nguyen AH; Vaudreuil AM; Huerter CJ
Int J Dermatol; 2017 Mar; 56(3):e47-e55. PubMed ID: 28181222
[TBL] [Abstract][Full Text] [Related]
11. Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review.
Levin MK; Ng E; Bae YS; Brauer JA; Geronemus RG
Lasers Surg Med; 2016 Feb; 48(2):181-7. PubMed ID: 26922302
[TBL] [Abstract][Full Text] [Related]
12. A split-face, evaluator-blind randomized study on the early effects of Q-switched Nd:YAG laser versus Er:YAG micropeel in light solar lentigines in Asians.
Jun HJ; Kim SM; Choi WJ; Cho SH; Lee JD; Kim HS
J Cosmet Laser Ther; 2014 Apr; 16(2):83-8. PubMed ID: 24409833
[TBL] [Abstract][Full Text] [Related]
13. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
Gokalp H; Akkaya AD; Oram Y
J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of 1,444nm Nd:YAG laser for xanthelasma palpebrarum.
Park JH; Ryu SI; Kim IH
J Cosmet Laser Ther; 2020 Apr; 22(3):141-145. PubMed ID: 32436411
[TBL] [Abstract][Full Text] [Related]
15. Q-switched Nd:YAG laser treatment for labial lentigines associated with Peutz-Jeghers syndrome.
Ge Y; Jia G; Lin T
J Dtsch Dermatol Ges; 2015 Jun; 13(6):551-5. PubMed ID: 26018367
[TBL] [Abstract][Full Text] [Related]
16. Fractional, nonablative Q-switched 1,064-nm neodymium YAG laser to rejuvenate photoaged skin: a pilot case series.
Luebberding S; Alexiades-Armenakas MR
J Drugs Dermatol; 2012 Nov; 11(11):1300-4. PubMed ID: 23135078
[TBL] [Abstract][Full Text] [Related]
17. Low-fluence Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser for the treatment of facial partial unilateral lentiginosis in Koreans.
Lee Y; Choi EH; Lee SW
Dermatol Surg; 2012 Jan; 38(1):31-7. PubMed ID: 22093176
[TBL] [Abstract][Full Text] [Related]
18. Long-wave plasma radiofrequency ablation for treatment of xanthelasma palpebrarum.
Baroni A
J Cosmet Dermatol; 2019 Feb; 18(1):121-123. PubMed ID: 29493071
[TBL] [Abstract][Full Text] [Related]
19. High-fluence 1064-nm Q-Switched Nd:YAG laser: Safe and effective treatment of café-au-lait macules in Asian patients.
Baek JO; Park IJ; Lee KR; Ryu HR; Kim J; Lee S; Kim YR; Hur H
J Cosmet Dermatol; 2018 Jun; 17(3):380-384. PubMed ID: 29726114
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acquired bilateral nevus of ota-like macules (Hori's nevus) with a combination of the 532 nm Q-Switched Nd:YAG laser followed by the 1,064 nm Q-switched Nd:YAG is more effective: prospective study.
Ee HL; Goh CL; Khoo LS; Chan ES; Ang P
Dermatol Surg; 2006 Jan; 32(1):34-40. PubMed ID: 16393596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
